Puma Biotechnology, Inc. financial data

Symbol
PBYI on Nasdaq
Industry
Pharmaceutical Preparations
Location
10880 Wilshire Blvd., Suite 2150, Los Angeles, California
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INNOVATIVE ACQUISITIONS CORP (to 10/4/2011)
Latest financial report
10-Q - Q2 2024 - Aug 1, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 152 % -23.1%
Quick Ratio 7.83 % -10.4%
Debt-to-equity 345 % -51.9%
Return On Equity 18.2 %
Return On Assets 4.09 %
Operating Margin 8.63 % -8.39%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 49M shares +3.24%
Common Stock, Shares, Outstanding 48.5M shares +3.22%
Entity Public Float 141M USD +26.4%
Common Stock, Value, Issued 5K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.3M shares +3.28%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares +2.31%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 219M USD -4.77%
Research and Development Expense 60.2M USD -30.3%
Costs and Expenses 200M USD -3.94%
Operating Income (Loss) 18.9M USD -12.7%
Nonoperating Income (Expense) -8.84M USD +62.2%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 10.1M USD -279%
Income Tax Expense (Benefit) 1.35M USD +93.8%
Net Income (Loss) Attributable to Parent 8.72M USD -313%
Earnings Per Share, Basic 0.19 USD/shares -280%
Earnings Per Share, Diluted 0.18 USD/shares -280%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 67.1M USD +11.9%
Marketable Securities, Current 29.7M USD +106%
Cash, Cash Equivalents, and Short-term Investments 88.8M USD +86.3%
Accounts Receivable, after Allowance for Credit Loss, Current 28.1M USD -10.2%
Inventory, Net 9.05M USD +18.6%
Other Assets, Current 241K USD -57.9%
Assets, Current 138M USD +16.2%
Property, Plant and Equipment, Net 680K USD -30.4%
Operating Lease, Right-of-Use Asset 6.23M USD -37.1%
Assets 205M USD +2.25%
Accounts Payable, Current 13.5M USD +73.2%
Employee-related Liabilities, Current 4.66M USD +1.15%
Accrued Liabilities, Current 39M USD +9.89%
Liabilities, Current 104M USD +73%
Operating Lease, Liability, Noncurrent 4.36M USD -54.2%
Other Liabilities, Noncurrent 121K USD
Liabilities 156M USD -8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -32K USD -433%
Retained Earnings (Accumulated Deficit) -1.35B USD +0.64%
Stockholders' Equity Attributable to Parent 48.5M USD +59.6%
Liabilities and Equity 205M USD +2.25%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 11.2M USD +326%
Net Cash Provided by (Used in) Financing Activities 0 USD
Net Cash Provided by (Used in) Investing Activities -19.1M USD -9.34%
Common Stock, Shares Authorized 100M shares 0%
Common Stock, Shares, Issued 48.5M shares +3.22%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.83M USD +47.1%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.91M USD 0%
Deferred Tax Assets, Valuation Allowance 369M USD -1.66%
Deferred Tax Assets, Gross 372M USD -1.58%
Operating Lease, Liability 9.52M USD -31.9%
Depreciation 400K USD -20%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 8.69M USD -314%
Lessee, Operating Lease, Liability, to be Paid 10.4M USD -35.4%
Property, Plant and Equipment, Gross 8.56M USD -0.97%
Operating Lease, Liability, Current 5.16M USD +15.7%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.51M USD -74.8%
Lessee, Operating Lease, Liability, to be Paid, Year One 5.98M USD +3.07%
Operating Lease, Weighted Average Discount Rate, Percent 0.11 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 894K USD -58.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.51M USD -74.8%
Deferred Tax Assets, Operating Loss Carryforwards 241M USD -4.96%
Unrecognized Tax Benefits 2.81M USD +11.5%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.51M USD 0%
Operating Lease, Payments 1.58M USD +5.34%
Amortization of Intangible Assets 9.7M USD +10.2%
Share-based Payment Arrangement, Expense 9.42M USD -12.2%
Interest Expense 13.4M USD +9.29%